Disclosures
Stefan M. Pulst, MD, Dr med, FAAN
| Scientific Advisory Boards | |
| National Ataxia Foundation, Medical Research Advisory Board Hertie Institute for Brain Science, University of Tuebingen | |
| Editorial Boards | |
| editorial boards: Journal of Cerebellum, NeuroMolecular Medicine, Nature Clinical Practice Neurology Editor-in-Chief: Neurology: Genetics | |
| Patents | |
| Nucleic acids encoding ataxin-2 binding proteins; Nucleic acid encoding Schwannomin-binding-proteins and products related thereto; Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide; Methods of detecting spinocerebellar ataxia-2 nucleic acids; Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto; Schwannomin-binding-proteins; Compositions and methods for spinocerebellar ataxia; Methods For Modulating Ataxin2 Expression | |
| Publishing Royalties | |
| The Ataxias (Churchill Livingston, 2007), Genetics in Neurology (ANN Press, 2005), Genetics of Movement Disorders (Academic Press, 2003), Neurogenetics (Oxford University Press, 2000), Molecular Genetic Testing in Neurology, 2nd - 5th (AAN Press, 1996) | |
| Research Support, Government Entities | |
| (1) 2010-2012 National Institutes of Health (RC1NS068897): CLINICAL RESEARCH CONSORTIUM FOR SPINOCEREBELLAR ATAXIAS, 9/1/2009-8/31/2012 (Principal Investigator of genomics core and site PI). (2) 2010-2013 National Institutes of Health (RC4NS073009): Drug discovery for Spinocerebellar ataxia type 2 (SCA2). 9/1/2010-8/31/2013 (Principle Investigator, Co-PI, D. Scoles). (3) 2013-2015 National Institutes of Health (R21NS081182): Antisense oligonucleotides for the treatment of spinocerebellar ataxia type 2. 07/01/2013 to 06/30/2015 (Co- PI with D. Scoles). (4) 2013-2016 National Institutes of Health (R21NS079852): Identification of a mutation causing Purkinje cell degeneration in the rat. 03/01/2013 to 02/28/2016. (Principle Investigator). (5) 2014-2021 National Institutes of Health (R37NS33123): Spinocerebellar ataxia type 2: gene and gene product. 9/30/14-6/30/2021. (Principal Investigator). | |
| License fee payments, Technology or Inventions | |
| University of Utah (license for invention & technologies | |
| Royalty Payments, Technology or Inventions | |
| University of Utah | |